1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Myra Ramdenbourg
Myra Ramdenbourg
Articles (187) 

Weekly CFO Sells Highlight: Facebook Inc., Cardinal Health Inc., Alexion Pharmaceuticals Inc., Thermo Fisher Scientific Inc.

February 10, 2014 | About:

According to GuruFocus Insider Data, the recent CFO sales were: Facebook Inc., Cardinal Health Inc., Alexion Pharmaceuticals Inc. and Thermo Fisher Scientific Inc.

Facebook Inc. (NASDAQ:FB): CFO David A. Ebersman Sold 23,400 Shares

On 02/05/2014, CFO David A. Ebersman sold 23,400 shares at an average price of $62.36. The price of the stock has increased by 3.14% since. Facebook Inc. has a market cap of $164 billion and its shares were traded at around $64.32. The company has a P/E ratio of 159.20 and P/S ratio of 24.46.

Facebook Inc. announced their 2013 fourth quarter results with revenues of $2.59 billion and gross profit of $2.1 billion; the net income was $520 million. The 2013 total revenue for Facebook Inc. was $7.87 billion, a 55% increase from the 2012 total revenue. The 2013 gross profit was $6 billion, a 61% increase from the 2012 gross profit. The 2013 net income was $1.5 billion.

On 01/31/2014, Director Marc L. Andreessen sold 1,274,869 shares at an average price of $61.63. The price of the stock has increased by 5.05% since. On 01/29/2014, Chief Accounting Officer Jas Athwal sold 500 shares at an average price of $54.60. The price of the stock has increased by 17.8% since. On 12/26/2013, COB and CEO, 10% Owner Mark Zuckerberg sold 41,350,000 shares at an average price of $55.05. The price of the stock has increased by 16.84% since.

Cardinal Health Inc. (NYSE:CAH): CFO Jeffrey William Henderson Sold 253,190 Shares

On 02/03/2014, CFO Jeffrey William Henderson sold 253,190 shares at an average price of $67.54. The price of the stock has increased by 0.52% since. Cardinal Health Inc. has a market cap of $23.16 billion and its shares were traded at around $67.54. The company has a P/E ratio of 58.60 and P/S ratio of 0.23; additionally, Cardinal Health Inc. has a dividend yield of 1.75%.

Cardinal Health Inc. announced their 2013 third quarter results with revenues of $24.5 billion and gross profit of $1.26 billion; the net income was $339 million. The 2013 total revenue for Cardinal Health Inc. was $101 billion, a 6% decrease from the 2012 total revenue. The 2013 gross profit was $4.9 billion, an 8% increase from the 2012 gross profit. The 2013 net income was $334 million.

On 02/05/2014, Director Calvin Darden sold 5,282 shares at an average price of $65.43. The price of the stock has increased by 3.22% since. On 02/05/2014, Director Gregory B. Kenny sold 18,175 shares at an average price of $65.39. The price of the stock has increased by 3.29% since. On 11/11/2013, Chairman and CEO George S. Barrett sold 200,000 shares at an average price of $62.71. The price of the stock has increased by 7.7% since.

Alexion Pharmaceuticals Inc. (NASDAQ:ALXN): EVP and CFO Vikas Sinha Sold 3,552 Shares

On 02/04/2014, EVP and CFO Vikas Sinha sold 3,552 shares at an average price of $154.47. The price of the stock has increased by 5.93% since. Alexion Pharmaceuticals Inc. has a market cap of $32.08 billion and its shares were traded at around $163.63. The company has a P/E ratio of 92.80 and P/S ratio of 22.89; over the past five years, Alexion Pharmaceuticals Inc. had an annual average earnings growth of 68.50%.

Alexion Pharmaceuticals Inc. announced their 2013 third quarter results with revenues of $400.4 million and gross profit of $349 million; the net income was $93.79 million. The 2012 total revenue for Alexion Pharmaceuticals Inc. was $1.1 billion, a 45% increase from the 2011 total revenue. The 2012 gross profit was $1.06 billion, a 54% increase from the 2011 gross profit. The 2012 net income was $254.8 million.

On 02/04/2014, CEO Leonard Bell sold 11,790 shares at an average price of $154.50. The price of the stock has increased by 5.92% since. On 02/03/2014, Director Larry Mathis sold 80,729 shares at an average price of $157.50. The price of the stock has increased by 3.89% since. On 02/03/2014, Director Max Link sold 40,000 shares at an average price of $155.16. The price of the stock has increased by 5.46% since.

Thermo Fisher Scientific Inc. (NYSE:TMO): Senior VP and CFO Peter M. Wilver Sold 91,897 Shares

On 02/07/2014, Senior VP and CFO Peter M. Wilver sold 91,897 shares at an average price of $117.77. The price of the stock has increased by 2.22% since. Thermo Fisher Scientific Inc. has a market cap of $42.56 billion and its shares were traded at around $117.77. The company has a P/E ratio of 32.80 and P/S ratio of 3.32 with a dividend yield of 0.51%. Over the past 10 years, Thermo Fisher Scientific Inc. had an annual average earnings growth of 16.60%. GuruFocus rated Thermo Fisher Scientific Inc. the business predictability rank of 4.5-star.

Thermo Fisher Scientific Inc. announced their 2013 third quarter results with revenues of $3.19 billion and gross profit of $1.3 billion; the net income was $317.6 million. The 2012 total revenue for Thermo Fisher Scientific Inc. was $12.5 billion, an 8% increase from the 2011 total revenue. The 2012 gross profit was $5.3 billion, a 10% increase from the 2011 gross profit. The 2012 net income was $1.2 billion.

On 02/06/2014, Director Jim P. Manzi sold 6,000 shares at an average price of $114.26. The price of the stock has increased by 3.07% since. On 02/06/2014, Firector William G. Parrett sold 18,000 shares at an average price of $114.33. The price of the stock has increased by 3.01% since. On 09/16/2013, Executive Vice President Alan J. Malus sold 4,000 shares at an average price of $91.87. The price of the stock has increased by 28.19% since.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 5.0/5 (1 vote)

Comments

Please leave your comment:


GuruFocus Mobile App


User Generated Screeners


pbarker46Shiller PE < 7
DANGORDON5-4-16
DANGORDONCLEAN ROE
DANGORDONROE
rael2222tripla A/1
rolandtianLarge Buy screen
MasonQDTGolden Few, low cap
Ahmadou.DiarraContinu
cpetrouPetain Mini Buffet
Ahmadou.DiarraBest Of Allstar 2

Select portfolio(s):

  • Loading...

Why you are interested?

Your selection and notes will be stored in your portfolio.

Login to add portfolio
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK